Buy Brainstorm Cell Therapeutics Stock | BCLI Stock Price & Latest News | Public
BCLI

Brainstorm Cell Therapeutics

$0.00 (0.00%)Today
    Small Market Cap

    About BCLI

    Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective tr...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.11
    -0.21
    -0.32
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.28

    Actual EPS
    Q4 2020

    Stats

    Market Cap$533,45M
    Volume9,87k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$17.20
    1 Year Low$3.58
    Open$17.36
    High$17.36
    Low$16.06

    Buy any stock with any amount of money.

    Download the App
    Download the app